Informations:
Erreur:
ID
29141
Description
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.; ODM derived from: https://clinicaltrials.gov/show/NCT00744926
Lien
https://clinicaltrials.gov/show/NCT00744926
Mots-clés
Versions (1)
- 28/02/2018 28/02/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
28 février 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Diabetes Mellitus, Type 2 NCT00744926
Eligibility Diabetes Mellitus, Type 2 NCT00744926
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT00744926
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Adult | Age
Item
adult patients, 18-80 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Pharmaceutical Preparations naive | Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy Absent | Exercise Absent
Item
drug naive patients with type 2 diabetes uncontrolled with diet and exercise;
boolean
C0013227 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2])
C0012159 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0015259 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0919936 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2])
C0012159 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0015259 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Anti-GAD antibody negative
Item
tested negative for anti-gad antibodies;
boolean
C1167898 (UMLS CUI [1])
Fasting C-peptide level
Item
c-peptide (fasting) >=1.0ng/ml
boolean
C2208720 (UMLS CUI [1])
Glucohemoglobin measurement
Item
hba1c >=6.5% and <=10.0% at screening;
boolean
C0202054 (UMLS CUI [1])
Body mass index | Asians
Item
bmi >=25 (>23 for asians) and <=45kg/m2 at screening;
boolean
C1305855 (UMLS CUI [1])
C0078988 (UMLS CUI [2])
C0078988 (UMLS CUI [2])
Stable body weight Duration
Item
stable weight +/- 5% for at least 12 weeks prior to screening.
boolean
C0517386 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
Diabetes Mellitus, Insulin-Dependent | Complications of Diabetes Mellitus Metabolic | Ketoacidosis | Hyperosmolar Coma
Item
history of type 1 diabetes mellitus or acute metabolic diabetic complications such as ketoacidosis or hyperosmolar coma in the previous 6 months;
boolean
C0011854 (UMLS CUI [1])
C0342257 (UMLS CUI [2,1])
C0311400 (UMLS CUI [2,2])
C0220982 (UMLS CUI [3])
C0020457 (UMLS CUI [4])
C0342257 (UMLS CUI [2,1])
C0311400 (UMLS CUI [2,2])
C0220982 (UMLS CUI [3])
C0020457 (UMLS CUI [4])
Complications of Diabetes Mellitus Clinical Significance
Item
evidence of clinically significant diabetic complications;
boolean
C0342257 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,2])
Poorly controlled diabetes mellitus Symptomatic
Item
symptomatic poorly controlled diabetes;
boolean
C0554876 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,2])
Myocardial Infarction | Coronary Artery Bypass Surgery | Cardiomyopathy Post Transplantation | Cerebrovascular accident
Item
myocardial infarction, coronary artery bypass surgery, post-transplantation cardiomyopathy or stroke within the previous 6 months;
boolean
C0027051 (UMLS CUI [1])
C0010055 (UMLS CUI [2])
C0878544 (UMLS CUI [3,1])
C0687676 (UMLS CUI [3,2])
C0040732 (UMLS CUI [3,3])
C0038454 (UMLS CUI [4])
C0010055 (UMLS CUI [2])
C0878544 (UMLS CUI [3,1])
C0687676 (UMLS CUI [3,2])
C0040732 (UMLS CUI [3,3])
C0038454 (UMLS CUI [4])
Hemoglobinopathy | Chronic anemia
Item
known hemoglobinopathy or chronic anemia.
boolean
C0019045 (UMLS CUI [1])
C0581384 (UMLS CUI [2])
C0581384 (UMLS CUI [2])